Literature DB >> 2831405

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

J D Fingeroth1, M L Clabby, J D Strominger.   

Abstract

The Epstein-Barr virus/C3d receptor (EBVR-CR2) was detected on three T-lymphoblastoid cell lines. The apparent Mrs of purified EBVR-CR2 of T-cell and B-cell origin were identical. The N-terminal amino acid sequence from the T-cell EBVR-CR2 confirmed the placement of this receptor in a multigene family of complement regulatory proteins. All EBVR-CR2-positive T-cell lines were T6 and T4-T8 antigen positive.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2831405      PMCID： PMC253159          DOI： 10.1128/JVI.62.4.1442-1447.1988

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  55 in total

1.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  Association of Epstein-Barr virus with thymic carcinoma.

Authors:  S Leyvraz; W Henle; A P Chahinian; C Perlmann; G Klein; R E Gordon; M Rosenblum; J F Holland
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

3.  A modified Chou and Fasman protein structure algorithm.

Authors:  W W Ralph; T Webster; T F Smith
Journal:  Comput Appl Biosci       Date:  1987-09

4.  Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes.

Authors:  J C Gorga; J Foran; S J Burakoff; J L Strominger
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood.

Authors:  C Dezutter-Dambuyant; D Schmitt; M Faure; G Cordier; J Thivolet
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

6.  gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

Authors:  R Frade; M Barel; B Ehlin-Henriksson; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

Authors:  T F Tedder; L T Clement; M D Cooper
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

8.  The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.

Authors:  D M Knowles; L D Dodson; R Raab; R S Mittler; M A Talle; G Goldstein
Journal:  Diagn Immunol       Date:  1983

9.  Early events in Epstein-Barr virus infection provide a model for B cell activation.

Authors:  D A Thorley-Lawson; K P Mann
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Human genes for three complement components that regulate the activation of C3 are tightly linked.

Authors:  S Rodriguez de Cordoba; D M Lublin; P Rubinstein; J P Atkinson
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307
View more
  24 in total

1.  Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.

Authors:  H Illges; M Braun; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 2.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

Review 3.  Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence.

Authors:  D C Bloom; K M Edwards; C Hager; R W Moyer
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.

Authors:  James M Kovacs; Jonathan P Hannan; Elan Z Eisenmesser; V Michael Holers
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

Review 6.  Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.

Authors:  Dong Liu; Jian-Ying Zhu; Zhong-Xiang Niu
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

7.  Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.

Authors:  M Guan; R D Zhang; B Wu; E E Henderson
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Identification of murine complement receptor type 2.

Authors:  J D Fingeroth; M A Benedict; D N Levy; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Authors:  Andrea E Prota; David R Sage; Thilo Stehle; Joyce D Fingeroth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line.

Authors:  G S Gras; D Dormont
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.